For research, professional, and investigational evaluation only. No exosome product is FDA-approved for therapeutic use in humans.
Devices
SphenoCath.
Nose-to-brain delivery catheter technology. Facilitates access to the sphenopalatine ganglion for targeted substance delivery evaluation. Single-use device.
Regulatory notice
Research, professional, and investigational use only.
This product is not FDA-approved for therapeutic use in humans. Specifications describe the characterized product and its formulation. They do not establish safety, efficacy, or clinical utility. Marketed to qualified professionals only.
Product documentation
Review SphenoCath documentation.
Request the available documentation package for this Prodigy Bio product. Documentation may include specifications, lot records, and other relevant materials.